OpenLegislation

Annex II

United Kingdom

Original text. Later amendments are not shown.

Index NoInternational Chemical nameEC NoCAS NoClassificationLabellingConcentration LimitsNotes
‘005-007-00-2

boric acid; [1]

boric acid [2]

233-139-2 [1]

234-343-4 [2]

10043-35-3 [1]

11113-50-1 [2]

Repr. Cat. 2; R60-61

T

R: 60-61

S: 53-45

Repr. Cat. 2; R60-61: C ≥ 5,5 %
015-182-00-7tetrapropan-2-yl (dichloromethanediyl)bis(phosphonate)430-630-510596-22-2

Xn; R22

Xi; R36

R43

Xn

R: 22-36-43

S: (2-)24-26-37

017-001-00-7chlorine231-959-57782-50-5

O; R8

T; R23

Xi; R36/37/38

N; R50

O; T; N

R: 8-23-36/37/38-50

S: (1/2-)9-45-61

N; R50: C ≥ 0,25 %
024-004-00-7sodium dichromate234-190-310588-01-9

O; R8

Carc. Cat. 2; R45

Muta. Cat. 2; R46

Repr. Cat. 2; R60-61

T+; R26

T; R25-48/23

Xn; R21

C; R34

R42/43

N; R50-53

O; T+; N

R: 45-46-60-61-8-21-25-26-34-42/43-48/23-50/53

S: 53-45-60-61

C; R34: C ≥ 10 %

Xi; R36/37/38: 5 % ≤ C < 10 %

R42/43: C ≥ 0,2 %

E

3

027-006-00-6cobalt di(acetate)200-755-871-48-7

Carc. Cat. 2; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R60

R42/43

N; R50-53

T; N

R: 49-60-42/43-68-50/53

S: 53-45-60-61

Carc. Cat. 2; R49: C ≥ 0,01 %

N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %

1
027-009-00-2cobalt dinitrate233-402-110141-05-6

Carc. Cat. 2; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R60

R42/43

N; R50-53

T; N

R: 49-60-42/43-68-50/53

S: 53-45-60-61

Carc. Cat. 2; R49: C ≥ 0,01 %

N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %

1
606-138-00-3(2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanone444-800-1141645-23-0

R10

Xn; R22-48/22

Xi; R38-41

R43

N; R50-53

Xn; N

R: 10-22-38-41-43-48/22-50/53

S: (2-)23-26-36/37/39-60-61

N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %

607-003-00-1chloroacetic acid201-178-479-11-8

T; R23/24/25

C; R34

N; R50

T; N

R: 23/24/25-34-50

S: (1/2-)26-36/37/39-45-61-63

C; R34: C ≥ 10 %

Xn; R36/37/38: 5 % ≤ C < 10 %

607-177-00-9

tribenuron-methyl (ISO)

methyl 2-[N-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-N-methylcarbamoylsulfamoyl]benzoate

401-190-1101200-48-0

R43

N; R50-53

Xi; N

R: 43-50/53

S: (2-)24-37-46-60-61

N; R50-53: C ≥ 0,25 %

N; R51-53: 0,025 % ≤ C < 0,25 %

R52-53: 0,0025 % ≤ C < 0,025 %

608-057-00-94-(cyanomethyl)-4-methylmorpholin-4-ium hydrogen sulfate431-200-1208538-34-5

Xn; R22

Xi; R41

R43

Xn

R: 22-41-43

S: (2-)22-24-26-37/39

612-050-00-6cyclohexylamine203-629-0108-91-8

R10

Repr. Cat. 3; R62

Xn; R21/22

C; R34

C

R: 10-21/22-34-62

S: (1/2-)26-36/37/39-45

C; R34: C ≥ 10 %

Xi; R36/38: 2 % ≤ C < 10 %

613-010-00-0

ametryn (ISO);

N-ethyl-N′-isopropyl-6-(methylthio)-1,3,5-triazine-2,4-diamine

212-634-7834-12-8

Xn; R22

N; R50-53

Xn; N

R: 22-50/53

S: (2-)36-60-61

N; R50-53: C ≥ 0,25 %

N; R51-53: 0,025 % ≤ C < 0,25 %

R52-53: 0,0025 % ≤ C < 0,025 %

613-120-00-9

bioresmethrin (ISO);

(5-benzyl-3-furyl)methyl (1R)-2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropanecarboxylate

249-014-028434-01-7N; R50-53

N

R: 50/53

S: 60-61

N; R50-53: C ≥ 0,025 %

N; R51-53: 0,0025 % ≤ C < 0,025 %

R52-53: 0,00025 % ≤ C < 0,0025 %

613-161-00-2(2,4-diaminopteridin-6-yl)methanol hydrobromide430-620-076145-91-0

Xn; R48/22

R43

R52-53

Xn

R: 43-48/22-52/53

S: (2-)22-36/37-61

613-139-00-2

metsulfuron-methyl (ISO);

methyl 2-{[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoyl]sulfamoyl}benzoate

—74223-64-6N; R50-53

N

R: 50/53

S: 60-61

N; R50-53: C ≥ 0,025 %

N; R51-53: 0,0025 % ≤ C < 0,025 %

R52-53: 0,00025 % ≤ C < 0,0025 %

613-204-00-5

oxadiargyl (ISO);

3-[2,4-dichloro-5-(2-propynyloxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one;

254-637-639807-15-3

Repr. Cat. 3; R63

Xn; R48/22

N; R50-53

Xn; N

R: 48/22-63-50/53

S: (2-)36/37-46-60-61

N; R50-53: C ≥ 0,025 %

N; R51-53: 0,0025 % ≤ C < 0,025 %

R52-53: 0,00025 % ≤ C < 0,0025 %’